InSphero
Business Services · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Wagistrasse 27a, Schlieren, Zurich, 8952...Phone Number
+41 445150490Website
www.insphero.comRevenue
$20.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About InSphero
InSphero is a biotechnology company that develops advanced 3D cell culture and organ-on-a-chip systems used in drug discovery and safety testing. Its platform produces human-like microtissues such as liver, tumor, and pancreatic models to help pharmaceutical companies study disease biology and evaluate drug effects more accurately before clinical trials.Explore more
InSphero Org Chart
MM
Administrative Assistant, Training
IK
Administrative Assistant
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InSphero your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once InSphero has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when InSphero launches new products
Check out if InSphero is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at InSphero
InSphero, which may be a good buyer, showed buying intent in Masked Content Topic
Check if InSphero has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on InSphero recently announced quarterly report
Click to see if InSphero had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined InSphero as Masked Content
Find 3 more new buyers
Compare Similar Companies to InSphero
Compare insights from companies similar to InSphero, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InSphero is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InSphero is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InSphero.
InSphero financials insights
Gather financial insights about InSphero, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$1.9M
2013
Series B
$2.2M
2015
Series C
$21.1M
Unspecified
$850K
2018
Unspecified
$10M
InSphero Tech Stack
A closer look at the technologies used by InSphero
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
InSphero News & Media
InSphero Accelerates Global Growth and US Expansion with Acquisition of PhenoVista Biosciences
Strategic acquisition strengthens InSphero’s US presence and expands advanced imaging and phenotypic analysis capabilities for drug discovery and safety testing SCHLIEREN, ZURICH, SWITZERLAND, May 21, 2026 /EINPresswire.com/ -- InSphero, the global …InSphero Launches 3D InSight™ DIGIT Platform for Early Gastrointestinal Toxicity Assessment
New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model SCHLIEREN , SWITZERLAND, April 14, 2026 /EINPresswire.com/ -- New Offering Integrates DOPPL’s Patient-Derived Intestinal …InSphero and PharmaNest From a Partnership to Advance Translational Fibrosis Research
SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital pathology company. …InSphero Expands 3D Cell Model Leadership with Acquisition of DOPPL SA and Sun Bioscience Gri3D Technology
InSphero acquires DOPPL SA and Sun Bio’s Gri3D® platform, creating a unified spheroid–organoid ecosystem for scalable, human-relevant 3D models for pharma R&D. SCHLIEREN, ZH, SWITZERLAND, November 11, 2025 /EINPresswire.com/ -- InSphero AG, the …
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InSphero
Sign Up For FreeTo access detailed company insights
InSphero is a biotechnology company that develops advanced 3D cell culture and organ-on-a-chip systems used in drug discovery and safety testing. Its platform produces human-like microtissues such as liver, tumor, and pancreatic models to help pharmaceutical companies study disease biology and evaluate drug effects more accurately before clinical t... Read More
